MAP
AXSM icon

Moody Aldrich Partners’s Axsome Therapeutics AXSM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.41M Sell
61,410
-929
-1% -$97K 1.24% 23
2025
Q1
$7.27M Buy
62,339
+17,201
+38% +$2.01M 1.52% 16
2024
Q4
$3.82M Sell
45,138
-15,506
-26% -$1.31M 0.71% 68
2024
Q3
$5.45M Sell
60,644
-1,107
-2% -$99.5K 0.99% 39
2024
Q2
$4.97M Sell
61,751
-3,908
-6% -$315K 0.97% 37
2024
Q1
$5.24M Sell
65,659
-1,207
-2% -$96.3K 0.89% 41
2023
Q4
$5.32M Sell
66,866
-6,767
-9% -$539K 0.96% 40
2023
Q3
$5.15M Buy
73,633
+8,940
+14% +$625K 0.98% 37
2023
Q2
$4.65M Buy
64,693
+32,114
+99% +$2.31M 0.9% 42
2023
Q1
$2.01M Sell
32,579
-19,567
-38% -$1.21M 0.41% 90
2022
Q4
$4.02M Sell
52,146
-70,115
-57% -$5.41M 0.82% 55
2022
Q3
$5.46M Buy
122,261
+79,721
+187% +$3.56M 1.12% 31
2022
Q2
$1.63M Buy
+42,540
New +$1.63M 0.32% 91
2022
Q1
Sell
-42,871
Closed -$1.62M 154
2021
Q4
$1.62M Sell
42,871
-8,023
-16% -$303K 0.23% 103
2021
Q3
$1.68M Buy
50,894
+6,914
+16% +$228K 0.21% 101
2021
Q2
$2.97M Sell
43,980
-585
-1% -$39.5K 0.42% 85
2021
Q1
$2.52M Buy
44,565
+952
+2% +$53.9K 0.36% 87
2020
Q4
$3.55M Sell
43,613
-75
-0.2% -$6.11K 0.57% 79
2020
Q3
$3.11M Buy
43,688
+13,512
+45% +$963K 0.65% 72
2020
Q2
$2.48M Sell
30,176
-32,030
-51% -$2.64M 0.53% 76
2020
Q1
$3.66M Buy
62,206
+17
+0% +$1K 1.1% 32
2019
Q4
$6.43M Sell
62,189
-10,896
-15% -$1.13M 1.32% 19
2019
Q3
$1.48M Buy
73,085
+1,510
+2% +$30.6K 0.39% 84
2019
Q2
$1.84M Buy
+71,575
New +$1.84M 0.47% 79